Literature DB >> 9445047

A vaccinia virus late transcription factor copurifies with a factor that binds to a viral late promoter and is complemented by extracts from uninfected HeLa cells.

C F Wright1, A E Hubbs, S K Gunasinghe, B W Oswald.   

Abstract

We have previously described a vaccinia virus late transcription factor, VLTF-X, which we found to be present in cells at early and late times in infection. In this study, transcription complementation assays were used to demonstrate that VLTF-X activity is also present in virion extracts and in the cytoplasm of uninfected HeLa cells. Mobility shift assays performed on various VLTF-X preparations revealed that a late promoter DNA-binding activity cochromatographed and cosedimented with VLTF-X activity. Competition experiments demonstrated that this binding was specific for the late promoter region of the probe and that late transcription was dramatically reduced by an oligonucleotide that blocked factor-DNA complex formation but was only minimally affected by an oligonucleotide that did not inhibit complex formation. These results suggest that a cellular factor may participate in vaccinia virus late transcription. These findings also confirm the requirement for VLTF-X and distinguish it from any of the previously described vaccinia virus late transcription factors, which have all been mapped to the viral genome. Finally, these studies also suggest that the biochemical role for VLTF-X may be in late promoter recognition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445047      PMCID: PMC124625     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  A transcription factor for expression of vaccinia virus late genes is encoded by an intermediate gene.

Authors:  C F Wright; J G Keck; M M Tsai; B Moss
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

Authors:  G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  In vitro synthesis of vaccinia virus late mRNA containing a 5' poly(A) leader sequence.

Authors:  C F Wright; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes.

Authors:  J G Keck; C J Baldick; B Moss
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

5.  Structure of vaccinia virus late promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

6.  Identification of factors specific for transcription of the late class of vaccinia virus genes.

Authors:  C F Wright; B Moss
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Energy requirement for specific transcription initiation by the human RNA polymerase II system.

Authors:  M Sawadogo; R G Roeder
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

8.  Promoter DNA contacts made by the vaccinia virus early transcription factor.

Authors:  S S Broyles; J Li; B Moss
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

9.  Recruitment of vaccinia virus RNA polymerase to an early gene promoter by the viral early transcription factor.

Authors:  J Li; S S Broyles
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

10.  Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation.

Authors:  M Hänggi; W Bannwarth; H G Stunnenberg
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  5 in total

1.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  A new vaccinia virus intermediate transcription factor.

Authors:  P Sanz; B Moss
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology.

Authors:  Patrícia N G Silva; Jamária A P Soares; Bruno S A F Brasil; Sarah V Nogueira; Anderson A Andrade; José C de Magalhães; Marisa B Bonjardim; Paulo C P Ferreira; Erna G Kroon; Oscar Bruna-Romero; Cláudio A Bonjardim
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

Review 4.  Poxvirus tropism.

Authors:  Grant McFadden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

5.  The Host Factor Early Growth Response Gene (EGR-1) Regulates Vaccinia virus Infectivity during Infection of Starved Mouse Cells.

Authors:  Leonardo C de Oliveira; Bruno S A F Brasil; Bethany Unger; Giliane S Trindade; Jonatas S Abrahão; Erna G Kroon; Paula Traktman; Cláudio A Bonjardim
Journal:  Viruses       Date:  2018-03-21       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.